534
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Microvascular dysfunction in normotensive, normoalbuminuric, normo- or hyperfiltrate type 2 diabetes

, , &
Pages 1191-1192 | Received 27 May 2013, Accepted 23 Jun 2013, Published online: 01 Aug 2013

References

  • Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Internat J Vasc Med. 2011;2011: Article ID 971524. doi: 10.1155/2011/971524
  • Futrakul N, Futrakul P. Normalization of kidney dysfunction in normotensive, normoalbuminuric type 2 diabetes. Ren Fail. 2013;35(7):1058--1059
  • Futrakul N, Kulapatana O, Futrakul P, et al. Enhanced peritubular capillary flow and renalfunction can be accomplished in normoalbuminuric type 2 diabetic nephropathy. Ren Fail. 2011;33:312–315
  • Remuzzi G, Macia M, Ruggenenti P. Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study. J Am Soc Nephrol. 2006;17:S90–S97
  • Futrakul P, Yenrudi S, Futrakul N, et al. Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999;33:886–891
  • Montanari A, Pela G, Musirri L, et al. Nitric oxide−angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type-1 diabetes. Am J Physiol Renal Physiol. 2013;305(1):F42--F51
  • Ustandag B, Canatan H, Cinkilinc N, et al. Angiotensin converting enzyme (ACE) activity levels in insulin -- independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy. Cell Biochem Funct. 2000;18:23–28
  • Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag. 2008;4:1061–1068
  • Futrakul N, Butthep P, Laohareungpanya N, et al. A defective angiogenesis in chronic kidney disease. Ren Fail. 2008;30(2):215–217
  • Palatini P. Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension. Nephrol Diab Transplant. 2012;27(5):1708--1714
  • Hilgers Karl F, Veelken R. Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol. 2005;16:574–575

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.